[1] |
中国医师协会风湿免疫科医师分会自身抗体检测专业委员会,国家风湿病数据中心,国家皮肤与免疫疾病临床医学研究中心. 自身免疫性肝病相关自身抗体检测的临床应用专家共识[J]. 中华内科杂志, 2021, 60(7):619-625.
|
[2] |
王睿, 王绮夏, 马雄. 肠道微生态与自身免疫性肝病[J]. 实用肝脏病杂志, 2020, 23(6):773-776.
|
[3] |
ARBUCKLE M R, MCCLAIN M T, RUBERTONE M V, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus[J]. N Engl J Med, 2003, 349(16):1526-1533.
DOI
URL
|
[4] |
郭亚平, 王春光, 刘欣, 等. 抗线粒体抗体-M2阳性体检人群原发性胆汁性肝硬化相关指标的调查分析[J]. 中华肝脏病杂志, 2014, 22(10):735-738.
|
[5] |
LINDOR K D, BOWLUS C L, BOYER J, et al. Primary biliary cholangitis:2018 practice guidance from the American association for the study of liver diseases[J]. Hepatology, 2019, 69(1):394-419.
DOI
URL
|
[6] |
原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015)[J]. 中华传染病杂志, 2016, 34(7):385-394.
|
[7] |
HANNAM S, BOGDANOS D P, DAVIES E T, et al. Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies[J]. Autoimmunity, 2002, 35(8):545-550.
PMID
|
[8] |
覃小梅, 李双杰. 新生儿急性肝衰竭的病因、诊断及治疗[J]. 临床肝胆病杂志, 2022, 38(2):260-263.
|
[9] |
TAYLOR S A, WHITINGTON P F. Neonatal acute liver failure[J]. Liver Transpl, 2016, 22(5):677-685.
DOI
URL
|
[10] |
刘蕾, 华益民, 周开宇. 新生儿狼疮综合征诊疗研究进展[J]. 中国循证儿科杂志, 2018, 13(3):231-235.
|
[11] |
LEE A Y S. A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity[J]. Rheumatol Int, 2017, 37(8):1323-1333.
DOI
URL
|
[12] |
AMBROSI A, DZIKAITE V, PARK J, et al. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239,but not other Ro52 epitopes,induce congenital heart block in a rat model[J]. Ann Rheum Dis, 2012, 71(3):448-454.
DOI
URL
|
[13] |
ØSTENSEN M, KHAMASHTA M, LOCKSHIN M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction[J]. Arthritis Res Ther, 2006, 8(3):209.
DOI
PMID
|
[14] |
TSUBOI H, SUMIDA T, NOMA H, et al. Maternal predictive factors for fetal congenital heart block in pregnant mothers positive for anti-SS-A antibodies[J]. Mod Rheumatol, 2016, 26(4):569-575.
DOI
PMID
|